Invited Speakers

검색

Day 3 – April 12 (Sat)

[BM2] Breakfast with Master 2 - Evolving IBD Care with Vaccination April 12 (Sat), 07:30-08:00 | Meeting Room 1+2
  • A Deep Dive into Shingles Prevention for IBD Patients
    Dongwoo Kim Korea University
    Korea

Day 3 – April 12 (Sat)

[SY7] Symposium 7 - Precision Medicine in IBD April 12 (Sat), 08:30-10:00 | Room A
  • Precision Biomarkers in IBD: Revolutionizing Personalized Treatment
    Raja Atreya University Hospital Erlangen
    Germany
  • Advancing IBD Histology: Integrating Precision Histology in IBD Management
    So-Woon Kim Kyung Hee University
    Korea
  • Precision Medicine, Uncovering the Risk Factors in IBD: Genes, Microbiome, and Environment
    Manasi Agrawal Icahn School of Medicine at Mount Sinai
    USA

Day 3 – April 12 (Sat)

[SY8] Symposium 8 - Latest Updates on Small Bowel Disease April 12 (Sat), 08:30-10:00 | Room B
  • Small Bowel Ulcers: Differential Diagnosis for Crohn’s Disease
    Takayuki Matsumoto Iwate Medical University
    Japan
  • Diagnostic Approach to Small Bowel Tumors: A Case-Based Discussion
    Eun Ran Kim Sungkyunkwan University
    Korea
  • Recent Updates in Small Bowel Endoscopy: New Devices and Indications
    Han Hee Lee The Catholic University of Korea
    Korea

Day 3 – April 12 (Sat)

[SY9] Symposium 9 - AI-Driven Transformation in Intestinal Disease Care April 12 (Sat), 08:30-10:00 | Room C
  • AI Endoscopy and IBD: A Peek Into the Future
    Peter Bossuyt Imelda GI Clinical Research Center
    Belgium
  • Application of AI Models in Diagnosis of Intestinal Diseases
    Young-Gon Kim Seoul National University
    Korea
  • Innovative Use of Large Language Models as Medical Chatbots for Intestinal Diseases
    Dennis Shung Yale School of Medicine
    USA

Day 3 – April 12 (Sat)

[ND] Nurse and Dietitian Session - Best IBD Care: Nursing, Nutrition, and Treatment (Kor) April 12 (Sat), 10:15-11:35 | Room C
  • The Role of Nurses in Quality Care of IBD
    Shin Ae Lee Severance Hospital
    Korea
  • Crohn’s Disease Exclusion Diet
    So hyun Park Eunpyeong St. Mary’s Hospital
    Korea
  • Understanding Adverse Events Related to the IBD Medications
    Hyo-Yeop Song Wonkwang University
    Korea
  • Issues in Health Insurance for Advanced Therapies
    Dong Hoon Baek Pusan National University
    Korea

Day 3 – April 12 (Sat)

[NW] IMKASID 2025 Nurse Network Meeting (Kor) April 12 (Sat), 11:40-12:20 | Room C
  • IBD 교육수가 신설을 위한 의료정책윤리위원회의 활동과 향후 계획
    Su Bum Park Pusan National University
    Korea
  • IBD 간호사의 현재와 미래
    Eun Ja Kwon Asan Medical Center
    Korea
  • Discussant
    Yun Kyung Cho Asan Medical Center
    Korea
  • Discussant
    Shin Ae Lee Severance Hospital
    Korea
  • Discussant
    Da Eun Kim Kyung Hee University Hospital
    Korea

Day 3 – April 12 (Sat)

[LS7] Luncheon Symposium 7 - New and Now: A Deep Dive into Ustekinumab for IBD Patients April 12 (Sat), 12:25-13:05 | Room A
  • Recent Update for the Treatment of Fibrostenosing Small Bowel Crohn’s Disease
    Takayuki Matsumoto Iwate Medical University
    Japan
  • Role of Ustekinumab for Patients in Bio-na?ve Ulcerative Colitis with the Long-Term Perspective
    Seong-Joon Koh Seoul National University
    Korea

Day 3 – April 12 (Sat)

[LS8] Luncheon Symposium 8 - The Most Experienced JAK-i, Tofacitinib in UC pfizer April 12 (Sat), 12:25-13:05 | Room B
  • Optimizing Tofacitinib Use in Ulcerative Colitis: Insights from Real-World Evidence
    Eun Soo Kim Kyungpook National University
    Korea
  • Deep Dive into the Safety of Tofacitinib
    Eun Mi Song Ewha Womans University
    Korea

Day 3 – April 12 (Sat)

[LS9] Luncheon Symposium 9 - Therapeutic Approaches for Better Patient Outcomeeisaikorea April 12 (Sat), 12:25-13:05 | Room C
  • Management of UC Patients with Advanced Therapy: JAK Inhibitors’ Role
    Soo-Young Na The Catholic University of Korea
    Korea
  • Jyseleca's Role in IBD Treatment: Insights from Clinical Experience
    Shintaro Akiyama University of Tsukuba
    Japan

Day 3 – April 12 (Sat)

[LS10] Luncheon Symposium 10 - Integrative Advances in GI Therapeutics: Microbiome Insights and Optimized Treatment with 5-ASA April 12 (Sat), 13:05-13:45 | Room A
  • Expanding Horizons of Microbiome Therapeutics: C. difficile Infection and Beyond
    Philippe Pinton Ferring Pharmaceuticals
    Denmark
  • Optimizing Therapeutic Approaches & Consensus Statements in IBD Treatment
    Won Moon Kosin University
    Korea

Day 3 – April 12 (Sat)

[PS] KASID Presidential Plenary Session - Leading the Way in Intestinal Diseases April 12 (Sat), 13:55-15:35 | Room A
  • [Plenary I] Targeting Cancer Stem Cells for Prevention and Treatment of Colorectal Neoplasia: Promises and Challenges
    Tae Il Kim Yonsei University
    Korea
  • [Plenary II] Novel Vagal Hepatic Nerve Stimulation Therapy for Enhancing Intestinal Regulatory T cells by the Fine Tuning via Central Nerve System
    Takanori Kanai Keio University
    Japan
  • [Plenary III] Disease Clearance in IBD: How Far Can We Go?
    Fernando Magro University of Porto
    Portugal
Hosted by
  • KASID
Supported by
Korea Tourism Organization
Seoul Tourism Organization
Diamond
abbvie
Celltrionph
Jassen
SAMSUNG BIOEPIS
Takeda
Platinum
DEAWOONG
FERRING PHARMACEUTICALS
YUHAN
Gold
Eisasi Korea Inc.
Pfizer
Bronze
gsk
TAEJOON